pembrolizumab
merck
['kn564', 'congrat', 'rcc,(-irccs),(-srcc),(-urcc)']
great discussion by dr. larkin on periop tx of rcc! we saw press releases: why 3 negative adjuvant trials but kn564 was positive for dfs with clean data? congrats to all investigators for finishing large phase 3 trials! #esmo2022 
Oncologist, Professor, clinical/translational research, Genitourinary Cancers, bladder, prostate, testis, Univ of Washington, Fred Hutch; views are mine